Sale!

Acetylcholinesterase Amniotic Fluid Test Cost

Original price was: 2,010 د.إ.Current price is: 1,810 د.إ.

-10%

The Acetylcholinesterase Amniotic Fluid Test is a prenatal diagnostic procedure performed to detect neural tube defects (NTDs) in the fetus, such as spina bifida and anencephaly. This test measures the levels of acetylcholinesterase (AChE), an enzyme that is normally found in the nervous system and red blood cells. Elevated levels of AChE in the amniotic fluid, which surrounds the fetus during pregnancy, can be an indicator of an open neural tube defect, suggesting that the fetus may have a condition where the spinal cord or brain has not developed properly.

Conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing and diagnostics, the Acetylcholinesterase Amniotic Fluid Test offers expectant parents an important tool for early detection of certain congenital abnormalities. The test is typically recommended by healthcare providers as a follow-up after other screening tests indicate a high risk of NTDs. It involves collecting a small sample of amniotic fluid through amniocentesis, a procedure where a needle is inserted into the uterus under ultrasound guidance.

The cost of the Acetylcholinesterase Amniotic Fluid Test at DNA Labs UAE is 1810 AED. This price reflects the specialized nature of the test and the expertise required to accurately interpret its results. Parents considering this test are encouraged to discuss its benefits, risks, and implications with their healthcare provider to make an informed decision about their prenatal care.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ACETYLCHOLINESTERASE AMNIOTIC FLUID Test

Test Cost: AED 1810.0

Symptoms, Diagnosis, and Referral Details

Test Name: ACETYLCHOLINESTERASE AMNIOTIC FLUID Test

Components: Gel Electrophoresis

Price: AED 1810.0

Sample Condition: 3 ml (1 mL min.) amniotic fluid in a sterile screw capped vial. Avoid blood contamination. Ship refrigerated or frozen. Indicate gestational age, collection date, clinical indications, and the AFP and MoM results if available on the Test Request Form. Sample should be drawn between 13-24 weeks gestation. Duly filled Test Send Out Consent Form is mandatory.

Report Delivery: 2-3 weeks

Method: Gel Electrophoresis

Test Type: Prenatal Diagnosis

Doctor: Gynecologist

Test Department: OS

Pre Test Information: Sample should be drawn between 13-24 weeks gestation. Indicate gestational age, collection date, clinical indications, and the AFP and MoM results if available on the Test Request Form. Duly filled Test Send Out Consent Form is mandatory.

Test Details

The acetylcholinesterase (AChE) amniotic fluid test is a diagnostic test used to determine if a fetus has certain neural tube defects, such as spina bifida or anencephaly. AChE is an enzyme that is normally found in high concentrations in the brain and spinal cord, but is also present in the amniotic fluid surrounding the fetus.

During the test, a sample of amniotic fluid is collected through a procedure called amniocentesis, which involves inserting a needle into the amniotic sac. The amniotic fluid sample is then tested for the presence of AChE. If there is an elevated level of AChE in the amniotic fluid, it may indicate a neural tube defect in the fetus. This is because the neural tube defects can cause the leakage of AChE from the developing nervous system into the amniotic fluid.

It is important to note that the AChE amniotic fluid test is not a definitive diagnostic test for neural tube defects, but rather a screening test. If the test results are abnormal, further testing, such as ultrasound or genetic testing, may be recommended to confirm the diagnosis.

Overall, the AChE amniotic fluid test is a valuable tool in prenatal screening for neural tube defects and can help guide further diagnostic and management decisions for the pregnancy.

Test Name ACETYLCHOLINESTERASE AMNIOTIC FLUID Test
Components
Price 1810.0 AED
Sample Condition 3 ml(1 mL min.) amniotic fluid in a sterile screw capped vial. Avoid blood contamination. Ship refrigerated or frozen. Indicate gestational age, collection date, clinical indications and the AFP and MoM results if available on the Test Request Form. Sample should be drawn between 13-24 weeks gestation. Duly filled Test Send Out Consent Formis mandatory.
Report Delivery 2-3 weeks
Method Gel Electrophoresis
Test type Prenatal Diagnosis
Doctor Gynecologist
Test Department: OS
Pre Test Information Sample should be drawn between 13-24 weeks gestation. Indicate gestational age, collection date, clinical indications and the AFP and MoM results if available on the Test Request Form. Duly filled Test Send Out Consent Formis mandatory.
Test Details

The acetylcholinesterase (AChE) amniotic fluid test is a diagnostic test used to determine if a fetus has certain neural tube defects, such as spina bifida or anencephaly. AChE is an enzyme that is normally found in high concentrations in the brain and spinal cord, but is also present in the amniotic fluid surrounding the fetus.

During the test, a sample of amniotic fluid is collected through a procedure called amniocentesis, which involves inserting a needle into the amniotic sac. The amniotic fluid sample is then tested for the presence of AChE.

If there is an elevated level of AChE in the amniotic fluid, it may indicate a neural tube defect in the fetus. This is because the neural tube defects can cause the leakage of AChE from the developing nervous system into the amniotic fluid.

It is important to note that the AChE amniotic fluid test is not a definitive diagnostic test for neural tube defects, but rather a screening test. If the test results are abnormal, further testing, such as ultrasound or genetic testing, may be recommended to confirm the diagnosis.

Overall, the AChE amniotic fluid test is a valuable tool in prenatal screening for neural tube defects and can help guide further diagnostic and management decisions for the pregnancy.